| Drug General Information |
| Drug ID |
DXB3AP
|
| Drug Name |
Dimethyl-[3-(1-phenyl-1H-benzoimidazol-5-yloxy)-propyl]-amine
|
| Synonyms |
CHEMBL312269
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Formula |
C18H21N3O
|
| Canonical SMILES |
CN(C)CCCOc1ccc2c(c1)ncn2c3ccccc3
|
| InChI |
InChI=1S/C18H21N3O/c1-20(2)11-6-12-22-16-9-10-18-17(13-16)19-14-21(18)15-7-4-3-5-8-15/h3-5,7-10,13-14H,6,11-12H2,1-2H3
|
| InChIKey |
TVCMMAFYYAKVLR-UHFFFAOYSA-N
|
| Target and Pathway |
| Target(s) |
Basic fibroblast growth factor receptor 1 |
Target Info |
|
[1]
|
|---|
| Platelet-derived growth factor receptor |
Target Info |
|
[1]
|
|
KEGG Pathway
|
MAPK signaling pathway
|
|
Ras signaling pathway
|
|
Rap1 signaling pathway
|
|
PI3K-Akt signaling pathway
|
|
Adherens junction
|
|
Signaling pathways regulating pluripotency of stem cells
|
|
Regulation of actin cytoskeleton
|
|
Pathways in cancer
|
|
Proteoglycans in cancer
|
|
Prostate cancer
|
|
Melanoma
|
|
Central carbon metabolism in cancer
|
|
NetPath Pathway
|
TCR Signaling Pathway
|
|
PANTHER Pathway
|
Angiogenesis
|
|
FGF signaling pathway
|
|
Pathway Interaction Database
|
Glypican 1 network
|
|
Syndecan-4-mediated signaling events
|
|
N-cadherin signaling events
|
|
FGF signaling pathway
|
|
WikiPathways
|
Regulation of Actin Cytoskeleton
|
|
Endochondral Ossification
|
|
MAPK Signaling Pathway
|
|
Mesodermal Commitment Pathway
|
|
Hair Follicle Development: Induction (Part 1 of 3)
|
|
Integrated Pancreatic Cancer Pathway
|
|
Signaling Pathways in Glioblastoma
|
|
Neural Crest Differentiation
|
|
Signaling by FGFR
|
| References |
| REF 1 | URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017 |
|---|
